Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.
Jayathilaka, N., Han, A., Gaffney, K.J., Dey, R., Jarusiewicz, J.A., Noridomi, K., Philips, M.A., Lei, X., He, J., Ye, J., Gao, T., Petasis, N.A., Chen, L.(2012) Nucleic Acids Res 40: 5378-5388
- PubMed: 22396528 
- DOI: 10.1093/nar/gks189
- Primary Citation of Related Structures:  
3MU6 - PubMed Abstract: 
Enzymes that modify the epigenetic status of cells provide attractive targets for therapy in various diseases. The therapeutic development of epigenetic modulators, however, has been largely limited to direct targeting of catalytic active site conserved across multiple members of an enzyme family, which complicates mechanistic studies and drug development ...